Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 2
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,896 | Dovepress* | 7,896+ | 2,665 | 10,561 | |
Totals | 7,896 | 2,665 | 10,561 | ||
*Since 23 October 2012 +Since July 2016 |
View citations on Google Scholar